Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial ; volume:19 ; number:1 ; day:15 ; month:10 ; year:2019 ; pages:1-10 ; date:12.2019
BMC cancer ; 19, Heft 1 (15.10.2019), 1-10, 12.2019
- Creator
-
Kondo, Masaaki
Morimoto, Manabu
Kobayashi, Satoshi
Ohkawa, Shinichi
Hidaka, Hisashi
Nakazawa, Takahide
Aikata, Hiroshi
Hatanaka, Takeshi
Takizawa, Daichi
Matsunaga, Kotaro
Okuse, Chiaki
Suzuki, Michihiro
Taguri, Masataka
Ishibashi, Takako
Numata, Kazushi
Maeda, Shin
Tanaka, Katsuaki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-019-6198-8
- URN
-
urn:nbn:de:101:1-2020021101051390035570
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kondo, Masaaki
- Morimoto, Manabu
- Kobayashi, Satoshi
- Ohkawa, Shinichi
- Hidaka, Hisashi
- Nakazawa, Takahide
- Aikata, Hiroshi
- Hatanaka, Takeshi
- Takizawa, Daichi
- Matsunaga, Kotaro
- Okuse, Chiaki
- Suzuki, Michihiro
- Taguri, Masataka
- Ishibashi, Takako
- Numata, Kazushi
- Maeda, Shin
- Tanaka, Katsuaki
- SpringerLink (Online service)
Other Objects (12)
Sorafenib : Sorafenib in der Behandlung des Radiojod-refraktären differenzierten Schilddrüsenkarzinoms
Optimierung der Sorafenib-Therapie
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation
Sorafenib-Induced Capillary Leak Syndrome
Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma
Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells
Sorafenib : aktuelle Therapieoptionen bei hepatozellulärem Karzinom
Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial
Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma
Sorafenib-Therapie des fortgeschrittenen Hepatozellulären Karzinoms : Validierung von etablierten Staging-Systemen und Konstruktion eines Sorafenib-spezifischen Prognosemodells
Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors
Sorafenib : Sorafenib in der Behandlung des Radiojod-refraktären differenzierten Schilddrüsenkarzinoms
Optimierung der Sorafenib-Therapie
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation
Sorafenib-Induced Capillary Leak Syndrome
Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma
Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells
Sorafenib : aktuelle Therapieoptionen bei hepatozellulärem Karzinom
Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial
Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma
Sorafenib-Therapie des fortgeschrittenen Hepatozellulären Karzinoms : Validierung von etablierten Staging-Systemen und Konstruktion eines Sorafenib-spezifischen Prognosemodells
Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors
Sorafenib : Sorafenib in der Behandlung des Radiojod-refraktären differenzierten Schilddrüsenkarzinoms
Optimierung der Sorafenib-Therapie
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation
Sorafenib-Induced Capillary Leak Syndrome
Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma
Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells
Sorafenib : aktuelle Therapieoptionen bei hepatozellulärem Karzinom
Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial
Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma
Sorafenib-Therapie des fortgeschrittenen Hepatozellulären Karzinoms : Validierung von etablierten Staging-Systemen und Konstruktion eines Sorafenib-spezifischen Prognosemodells